Science & Technology / Biotechnology / GenomeIndia — UPSC Mains Model Answer

India carries a disproportionate burden of conditions such as type 2 diabetes, tuberculosis susceptibility, and certain cardiovascular disorders. By cataloguing population-specific genetic variants, GenomeIndia can help identify biomarkers and risk alleles that global genomic databases — dominated by European ancestry data — have systematically missed. This enables more accurate polygenic risk scoring for Indian patients.

India's extraordinary linguistic, ethnic, and caste-based diversity makes it a natural archive of ancient human migration. Genomic data can corroborate and refine archaeological and linguistic evidence about the movement of populations — including ancestral South Indians, ancestral North Indians, and later migrations — providing a scientific basis for understanding subcontinent-level demographic history.

Genomic sequencing data informs target identification and immunogenetic research but does not directly translate into vaccine manufacture. Vaccine development requires pathogen genomics, immunological trials, and regulatory pipelines that are distinct from population-level human genomics. Conflating the two overstates the project's immediate clinical deliverables.

Responsible stewardship of sensitive genomic data demands robust consent frameworks, data localisation norms, and equitable benefit-sharing with sampled communities. The project's long-term credibility depends on transparent governance as much as on scientific output.